Embecta Corp. (EMBC)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research
View more

Current Price

as of Apr 17, 2025

$11.34

P/E Ratio

11.28

Market Cap

$659.24M

Description
Add to research
View more

Embecta Corp. engages in the provision of medical devices used in the treatment of diabetes. Its products include pen needles, syringes, and safety devices complemented by a digital application. The company was founded in 1924 and is headquartered in Parsippany, NJ.

Metrics
Add to research
View more

Overview

  • HQParsippany, NJ
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerEMBC
  • Price$11.340.00%

Trading Information

  • Market cap$659.24M
  • Float92.12%
  • Average Daily Volume (1m)621,554
  • Average Daily Volume (3m)585,473
  • EPS$1.01

Company

  • Revenue$1.11B
  • Rev growth (1yr)-5.55%
  • Net incomeN/A
  • Gross margin59.03%
  • EBITDA margin24.93%
  • EBITDA$65.30M
  • EV$2.59B
  • EV/Revenue2.33
  • P/E11.28
  • P/S0.60
  • P/BN/A
  • Debt/EquityN/A
Documents
Add to research
View more